UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

Inflammation and regeneration, 2020-10, Vol.40, p.1-24

Hashizume, Misato

2020

Link zum Volltext

Verfügbarkeit prüfen

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

Clinical science (1979), 2012-02, Vol.122 (4), p.143

2012

Link zum Volltext

Verfügbarkeit prüfen

High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1

Biochemical and biophysical research communications, 2010-12, Vol.403 (2), p.184-189

2010

Link zum Volltext

Verfügbarkeit prüfen

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis

Arthritis, 2011-01, Vol.2011, p.765624-8

2011

Link zum Volltext

Verfügbarkeit prüfen

Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)

PloS one, 2015-12, Vol.10 (12), p.e0145468-e0145468

2015

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights

International reviews of immunology, 2015-05, Vol.34 (3), p.265

2015

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis

Biological and Pharmaceutical Bulletin, 2008/06/01, Vol.31(6), pp.1159-1163

2008

Link zum Volltext

Verfügbarkeit prüfen

Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)

PloS one, 2016, Vol.11 (3), p.e0152341-e0152341

2016

Link zum Volltext

Verfügbarkeit prüfen

Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

Rheumatology international, 2010-01, Vol.30 (3), p.309-315

2010

Link zum Volltext

Verfügbarkeit prüfen

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Journal of translational medicine, 2018-06, Vol.16 (1), p.156-156, Article 156

2018

Link zum Volltext

Verfügbarkeit prüfen

Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice

Rheumatology international, 2011-11, Vol.31 (11), p.1445-1449

2011

Link zum Volltext

Verfügbarkeit prüfen

Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model

Arthritis research & therapy, 2012-04, Vol.14 (2), p.R96-R96

2012

Link zum Volltext

Verfügbarkeit prüfen

Striking Species Difference in the Contribution of Concentrative Nucleoside Transporter 2 to Nucleoside Uptake between Mouse and Rat Hepatocytes

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.3035-3038

2010

Link zum Volltext

Verfügbarkeit prüfen

CS2C-2-4 IL-6 in autoimmune diseases

Journal of Pharmacological Sciences, 2014-02, Vol.124 (suppl), p.71-71

Misato Hashizume

2014

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

Arthritis research & therapy, 2015-01, Vol.17, p.10-10

2015

Link zum Volltext

Verfügbarkeit prüfen

IL-6 and lipid metabolism

Inflammation and Regeneration, 2011, Vol.31(3), pp.325-333

2011

Link zum Volltext

Verfügbarkeit prüfen

IL-6 as a target in autoimmune disease and inflammation

Folia Pharmacologica Japonica, 2014, Vol.144(4), pp.172-177

2014

Link zum Volltext

Verfügbarkeit prüfen

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production

Rheumatology international, 2010-05, Vol.30 (7), p.917-923

2010

Link zum Volltext

Verfügbarkeit prüfen

IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system

Rheumatology international, 2009-10, Vol.29 (12), p.1449-1454

2009

Link zum Volltext

Verfügbarkeit prüfen

IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis

Rheumatology international, 2011, Vol.31 (1), p.127-131

2011

Link zum Volltext

Verfügbarkeit prüfen

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling

Rheumatology international, 2009-02, Vol.29 (4), p.397-401

2009

Link zum Volltext

Verfügbarkeit prüfen

Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

Arthritis research & therapy, 2015-01, Vol.17 (1), p.10-10

2015

Link zum Volltext

Verfügbarkeit prüfen

IL-6 and lipid metabolism

Inflammation and Regeneration, 2011, Vol.31 (3), p.325-333

2011

Link zum Volltext

Verfügbarkeit prüfen

Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD

JCI insight, 2017-07, Vol.2 (14)

2017

Link zum Volltext

Verfügbarkeit prüfen

IL-6/sIL-6R trans-signalling, but not TNF-[alpha] induced angiogenesis in a HUVEC and synovial cell co-culture system

Rheumatology international, 2009-10, Vol.29 (12), p.1449

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(25)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(18)
Humans
(13)
Animals
(10)
Rheumatology
(10)
Medicine
(9)
Male
(8)
Female
(7)
Medicine & Public Health
(7)
Tocilizumab
(7)
Interleukin-6
(6)
Interleukin-6 - Metabolism
(6)
Mice
(6)
Receptors, Interleukin-6 - Immunology
(6)
Antibodies, Monoclonal - Pharmacology
(5)
Immunology
(5)
Antibodies, Monoclonal, Humanized
(4)
Arthritis
(4)
Cells, Cultured
(4)
Il-6
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Outlook of IL-6 signaling blockade for COVID-19 pneumonia

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

High molecular weight hyaluronic acid inhibits IL-6-induced MMP production from human chondrocytes by up-regulating the ERK inhibitor, MKP-1

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis

Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)

Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights

Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-Induced Arthritis

Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)

Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule

Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate

Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice

Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model

Striking Species Difference in the Contribution of Concentrative Nucleoside Transporter 2 to Nucleoside Uptake between Mouse and Rat Hepatocytes

CS2C-2-4 IL-6 in autoimmune diseases

Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

IL-6 and lipid metabolism

IL-6 as a target in autoimmune disease and inflammation

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production

IL-6/sIL-6R trans-signalling, but not TNF-α induced angiogenesis in a HUVEC and synovial cell co-culture system

IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis

Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling

Peripheral blood CD4+CD25+CD127low regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response

IL-6 and lipid metabolism

Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD

IL-6/sIL-6R trans-signalling, but not TNF-[alpha] induced angiogenesis in a HUVEC and synovial cell co-culture system

Aktive Filter

Suchergebnisse filtern